Yatai Pharma has completed its first share buyback through centralized bidding, repurchasing approximately 3.34 million shares, representing 0.45% of the company's total share capital. The transaction price ranged from 5.91 yuan to 6.03 yuan per share, with a total transaction value of approximately 19.998 million yuan. The company previously announced a buyback plan with a total fund allocation of 10 million to 20 million yuan, at a price not exceeding 7 yuan per share, to be used for equity incentives or employee stock ownership plans.
Zhejiang Yatai Pharmaceutical Co LtdCompany completed its first share buyback, signaling confidence and supporting share price.
